FDA inspection

Takeda Manufacturing Austria AG: FDA inspection ending Jul 17, 2026

FDA inspection 1331016 · No Action Indicated (NAI) · Vienna

Key facts

Inspection ID 1331016
Firm Takeda Manufacturing Austria AG
FEI number 3002807133
City Vienna
Country Austria
Fiscal year 2026
Inspection end date Jul 17, 2026
Classification No Action Indicated (NAI)
Project area Blood and Blood Products
Product type Biologics

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections